- Latest available (Revised)
- Original (As made)
This is the original version (as it was originally made).
(This note is not part of the Regulations)
1. These Regulations amend the Biocidal Products Regulations (Northern Ireland) 2001 (S.R. 2001 No. 422) (“the 2001 Regulations”) to make further provision as regards Northern Ireland for the implementation of Directive 98/8/EC of the European Parliament and Council (O.J. No. L123, 24.4.98, p.1.) concerning the placing of biocidal products on the market.
2. These Regulations—
(a)implement Directive 2009/107/EC of the European Parliament and of the Council of 16 September 2009 amending Directive 98/8/EC concerning the placing of biocidal products on the market as regards the extension of certain time periods (“the Amending Directive”);
(b)update references and make minor corrections in the 2001 Regulations; and
(c)take account of developments that require further amendment to the 2001 Regulations.
3. The main changes made by these Regulations are set out in the following paragraphs.
4. Regulation 2(2) amends the definitions of “new active substance” and “placing on the market”. It also inserts a definition of “the fifth review regulation” and removes the definition of “the second review regulation”.
5. Regulation 2(3) makes a minor amendment and corrects a cross reference.
6. Regulation 2(4) amends time periods.
7. Regulation 2(5) extends the data protection periods for active substances from 14th May 2010 to 14th May 2014.
8. Regulation 2(6) extends the data protection periods for biocidal products from 14th May 2010 to 14th May 2014.
9. Regulation 2(7) adds the Medical Devices Regulations 2002 and the Plant Protection Products Regulations (Northern Ireland) 2005 to Schedule 2 and removes the Medical Devices Regulations 1994 and the Plant Protection Products Regulations (Northern Ireland) 1995.
10. Regulation 2(8) clarifies that a biocidal product can only remain on the UK market under its existing national authorisation if all the active substances within it are existing active substances and changes specific time periods.
11. In Great Britain the corresponding Regulations are the Biocidal Products (Amendment) Regulations 2010 (S.I. 2010/745).
12. A transposition note in relation to the implementation of the Amending Directive has been prepared. A copy may be obtained from the Health and Safety Executive for Northern Ireland, 83 Ladas Drive, Belfast, BT6 9FR.
Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area.
Original (As Enacted or Made): The original version of the legislation as it stood when it was enacted or made. No changes have been applied to the text.
Explanatory Memorandum sets out a brief statement of the purpose of a Statutory Rule and provides information about its policy objective and policy implications. They aim to make the Statutory Rule accessible to readers who are not legally qualified and accompany any Northern Ireland Statutory Rule or Draft Northern Ireland Statutory Rule laid before the UK Parliament during the suspension of the Northern Ireland Assembly.
Access essential accompanying documents and information for this legislation item from this tab. Dependent on the legislation item being viewed this may include:
Use this menu to access essential accompanying documents and information for this legislation item. Dependent on the legislation item being viewed this may include:
Click 'View More' or select 'More Resources' tab for additional information including: